Most Clicked StoriesMore >


Study: Stem cell transplant relieves symptoms of stiff person syndrome

AABB SmartBrief | Aug 26, 2014

Two women treated for stiff person syndrome are in clinical remission after receiving autologous hematopoietic stem cell transplants, according to a case report in JAMA Neurology. The patients were treated in 2009 and 2011 at Ottawa Hospital using a regimen of immunoablation followed by transplantation. MedicalDaily.com (08/25)


Aspirin prevents venous thromboembolism in trials

AABB SmartBrief | Aug 27, 2014

Researchers produce spinal cord stem cells

AABB SmartBrief | Aug 28, 2014

Nanotube-polymer structure promotes culturing of T cells

AABB SmartBrief | Aug 25, 2014

Vitamin D deficiency associated with poor lymphoma outcomes in seniors

AABB SmartBrief | Aug 27, 2014

WHO plan calls for $430 million to stop Ebola outbreak

AABB SmartBrief | Aug 27, 2014

Passive immunotherapy may prevent HIV, laboratory tests suggest

AABB SmartBrief | Aug 29, 2014

Reminder: Proposed 7th edition of Standards for Cellular Therapy Services available for public comment

AABB SmartBrief | Aug 27, 2014

Humanized antibody shows promise against Sudan strain of Ebola

AABB SmartBrief | Aug 29, 2014

Experimental anemia drug shows promise in safety study

AABB SmartBrief | Aug 28, 2014


Find AABB SmartBrief Issues by Date:



AABB News More >


Membership encouraged to vote on proposed AABB bylaws amendments at annual business meeting

AABB SmartBrief | Aug 29, 2014

Reminder: AABB board nomination by petition process closes tomorrow

AABB SmartBrief | Aug 28, 2014

Reminder: Proposed 7th edition of Standards for Cellular Therapy Services available for public comment

AABB SmartBrief | Aug 27, 2014

Blood centers to implement donor travel survey designed by AABB TTD Committee

AABB SmartBrief | Aug 26, 2014

Reminder: Advance discounted registration for Annual Meeting ends Wednesday, Aug. 27

AABB SmartBrief | Aug 25, 2014




Sign up for AABB SmartBrief



Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more